The cyclin-like protein spy1 regulates growth and division characteristics of the CD133+ population in human glioma

Cancer Cell

Volumn 25, Issue 1, 2014, Pages 64-76

  Lubanska, Dorota ^a   Market Velker, BrennaA ^a   deCarvalho, AnaC ^b   Mikkelsen, Tom ^b   FidalgodaSilva, Elizabeth ^a   Porter, LisaA ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CYCLIN DEPENDENT KINASE; PROTEIN SPY1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL DIVISION; GLIOMA; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICRODISSECTION; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PEPTIDES; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892429943     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.12.006     Document Type: Article

References (72)

1. Al Sorkhy M., Ferraiuolo R.M., Jalili E., Malysa A., Fratiloiu A.R., Sloane B.F., Porter L.A. The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer. BMC Cancer 2012, 12:45.
2. Artegiani B., Lange C., Calegari F. Expansion of embryonic and adult neural stem cells by in utero electroporation or viral stereotaxic injection. J.Vis. Exp. 2012, (68). pii: 4093.
3. Arumugam K., MacNicol M.C., Wang Y., Cragle C.E., Tackett A.J., Hardy L.L., MacNicol A.M. Ringo/cyclin-dependent kinase and mitogen-activated protein kinase signaling pathways regulate the activity of the cell fate determinant Musashi to promote cell cycle re-entry in Xenopus oocytes. J.Biol. Chem. 2012, 287:10639-10649.
4. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006, 66:7843-7848.
5. Boman B.M., Wicha M.S., Fields J.Z., Runquist O.A. Symmetric division of cancer stem cells-a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin. Pharmacol. Ther. 2007, 81:893-898.
6. Calegari F., Huttner W.B. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J.Cell Sci. 2003, 116:4947-4955.
7. Chen R., Nishimura M.C., Bumbaca S.M., Kharbanda S., Forrest W.F., Kasman I.M., Greve J.M., Soriano R.H., Gilmour L.L., Rivers C.S., et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010, 17:362-375.
8. Chen J., McKay R.M., Parada L.F. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 2012, 149:36-47.
9. Cheng A., Gerry S., Kaldis P., Solomon M.J. Biochemical characterization of Cdk2-Speedy/Ringo A2. BMC Biochem. 2005, 6:19.
10. Cheng A., Xiong W., Ferrell J.E., Solomon M.J. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. Cell Cycle 2005, 4:155-165.
11. Couturier L., Vodovar N., Schweisguth F. Endocytosis by Numb breaks Notch symmetry at cytokinesis. Nat. Cell Biol. 2012, 14:131-139.
12. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
13. deCarvalho A.C., Nelson K., Lemke N., Lehman N.L., Arbab A.S., Kalkanis S., Mikkelsen T. Gliosarcoma stem cells undergo glial and mesenchymal differentiation invivo. Stem Cells 2010, 28:181-190.
14. Dehay C., Kennedy H. Cell-cycle control and cortical development. Nat. Rev. Neurosci. 2007, 8:438-450.
15. Di Marcotullio L., Ferretti E., Greco A., De Smaele E., Po A., Sico M.A., Alimandi M., Giannini G., Maroder M., Screpanti I., Gulino A. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat. Cell Biol. 2006, 8:1415-1423.
16. Dobashi Y., Kudoh T., Matsumine A., Toyoshima K., Akiyama T. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J.Biol. Chem. 1995, 270:23031-23037.
17. Dobashi Y., Shoji M., Kitagawa M., Noguchi T., Kameya T. Simultaneous suppression of cdc2 and cdk2 activities induces neuronal differentiation of PC12 cells. J.Biol. Chem. 2000, 275:12572-12580.
18. Donovan L.K., Potter N.E., Warr T., Pilkington G.J. A prominin-1-rich pediatric glioblastoma: biologic behavior is determined by oxygen tension-modulated CD133 expression but not accompanied by underlying molecular profiles. Transl. Oncol. 2012, 5:141-154.
19. Durand B., Fero M.L., Roberts J.M., Raff M.C. p27Kip1 alters theresponse of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 1998, 8:431-440.
20. Fiano V., Ghimenti C., Schiffer D. Expression of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors in oligodendrogliomas in humans. Neurosci. Lett. 2003, 347:111-115.
21. Fischer P.M., Lane D.P. Inhibitors of cyclin-dependent kinases asanti-cancer therapeutics. Curr. Med. Chem. 2000, 7:1213-1245.
22. Golipour A., Myers D., Seagroves T., Murphy D., Evan G.I., Donoghue D.J., Moorehead R.A., Porter L.A. The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis. Cancer Res. 2008, 68:3591-3600.
23. Gönczy P. Mechanisms of asymmetric cell division: flies and worms pave the way. Nat. Rev. Mol. Cell Biol. 2008, 9:355-366.
24. Götz M., Huttner W.B. The cell biology of neurogenesis. Nat. Rev. Mol. Cell Biol. 2005, 6:777-788.
25. Guryanova O.A., Wu Q., Cheng L., Lathia J.D., Huang Z., Yang J., MacSwords J., Eyler C.E., McLendon R.E., Heddleston J.M., et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011, 19:498-511.
26. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells canarise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100:15178-15183.
27. Hidaka T., Hama S., Shrestha P., Saito T., Kajiwara Y., Yamasaki F., Sugiyama K., Kurisu K. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma. Anticancer Res. 2009, 29:597-603.
28. Hindley C., Philpott A. Co-ordination of cell cycle and differentiation in the developing nervous system. Biochem. J. 2012, 444:375-382.
29. Huang Y., Liu Y., Chen Y., Yu X., Yang J., Lu M., Lu Q., Ke Q., Shen A., Yan M. Peripheral nerve lesion induces an up-regulation of Spy1 in rat spinal cord. Cell. Mol. Neurobiol. 2009, 29:403-411.
30. Imai T., Tokunaga A., Yoshida T., Hashimoto M., Mikoshiba K., Weinmaster G., Nakafuku M., Okano H. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell. Biol. 2001, 21:3888-3900.
31. Jablonska B., Aguirre A., Vandenbosch R., Belachew S., Berthet C., Kaldis P., Gallo V. Cdk2 is critical for proliferation and self-renewal of neural progenitor cells in the adult subventricular zone. J.Cell Biol. 2007, 179:1231-1245.
32. Jane E.P., Premkumar D.R., Pollack I.F. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. J.Pharmacol. Exp. Ther. 2006, 319:1070-1080.
33. Jin F., Gao C., Zhao L., Zhang H., Wang H.T., Shao T., Zhang S.L., Wei Y.J., Jiang X.B., Zhou Y.P., Zhao H.Y. Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor. Brain Res. 2011, 1368:82-90.
34. Kelly S.E., Di Benedetto A., Greco A., Howard C.M., Sollars V.E., Primerano D.A., Valluri J.V., Claudio P.P. Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS ONE 2010, 5:e10035.
35. Kerosuo L., Piltti K., Fox H., Angers-Loustau A., Häyry V., Eilers M., Sariola H., Wartiovaara K. Myc increases self-renewal in neural progenitor cells through Miz-1. J.Cell Sci. 2008, 121:3941-3950.
36. Kippin T.E., Martens D.J., van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev. 2005, 19:756-767.
37. Knoblich J.A., Jan L.Y., Jan Y.N. Asymmetric segregation of Numb and Prospero during cell division. Nature 1995, 377:624-627.
38. Korur S., Huber R.M., Sivasankaran B., Petrich M., Morin P., Hemmings B.A., Merlo A., Lino M.M. GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS ONE 2009, 4:e7443.
39. Kranenburg O., Scharnhorst V., Van der Eb A.J., Zantema A. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J.Cell Biol. 1995, 131:227-234.
40. Lange C., Calegari F. Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells. Cell Cycle 2010, 9:1893-1900.
41. Lange C., Huttner W.B., Calegari F. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 2009, 5:320-331.
42. Lathia J.D., Gallagher J., Heddleston J.M., Wang J., Eyler C.E., Macswords J., Wu Q., Vasanji A., McLendon R.E., Hjelmeland A.B., Rich J.N. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010, 6:421-432.
43. Lathia J.D., Hitomi M., Gallagher J., Gadani S.P., Adkins J., Vasanji A., Liu L., Eyler C.E., Heddleston J.M., Wu Q., et al. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis. 2011, 2:e200.
44. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
45. Lenormand J.L., Dellinger R.W., Knudsen K.E., Subramani S., Donoghue D.J. Speedy: a novel cell cycle regulator of the G2/M transition. EMBO J. 1999, 18:1869-1877.
46. Lu B., Rothenberg M., Jan L.Y., Jan Y.N. Partner of Numb colocalizes with Numb during mitosis and directs Numb asymmetric localization in Drosophila neural and muscle progenitors. Cell 1998, 95:225-235.
47. Li A., Walling J., Ahn S., Kotliarov Y., Su Q., Quezado M., Oberholtzer J.C., Park J., Zenklusen J.C., Fine H.A. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res. 2009, 69:2091-2099.
48. Li Z., Wang H., Eyler C.E., Hjelmeland A.B., Rich J.N. Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways. J.Biol. Chem. 2009, 284:16705-16709.
49. McAndrew C.W., Gastwirt R.F., Meyer A.N., Porter L.A., Donoghue D.J. Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27. Cell Cycle 2007, 6:1937-1945.
50. Middlemas D.S., Stewart C.F., Kirstein M.N., Poquette C., Friedman H.S., Houghton P.J., Brent T.P. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. Clin. Cancer Res. 2000, 6:998-1007.
51. Muto J., Imai T., Ogawa D., Nishimoto Y., Okada Y., Mabuchi Y., Kawase T., Iwanami A., Mischel P.S., Saya H., et al. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways. PLoS ONE 2012, 7:e33431.
52. Narita Y., Nagane M., Mishima K., Huang H.J., Furnari F.B., Cavenee W.K. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res. 2002, 62:6764-6769.
53. NCI. (2005). caIntegrator. http://rembrandt.nci.nih.gov.
54. Noseda M., Chang L., McLean G., Grim J.E., Clurman B.E., Smith L.L., Karsan A. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol. Cell. Biol. 2004, 24:8813-8822.
55. Pacey L.K.K., Stead S., Gleave J.A., Tomczyk K., Doering L.C. Neural stem cell culture: Neurosphere generation, immunocytochemical analysis and cryopreservation. Nat. Protoc. 2006, 1:215-222.
56. Porter L.A., Dellinger R.W., Tynan J.A., Barnes E.A., Kong M., Lenormand J.L., Donoghue D.J. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J.Cell Biol. 2002, 157:357-366.
57. Porter L.A., Kong-Beltran M., Donoghue D.J. Spy1 interacts with p27Kip1 to allow G1/S progression. Mol. Biol. Cell 2003, 14:3664-3674.
58. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
59. Sakakibara S., Nakamura Y., Yoshida T., Shibata S., Koike M., Takano H., Ueda S., Uchiyama Y., Noda T., Okano H. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc. Natl. Acad. Sci. USA 2002, 99:15194-15199.
60. Sasaki K., Tamura S., Tachibana H., Sugita M., Gao Y., Furuyama J., Kakishita E., Sakai T., Tamaoki T., Hashimoto-Tamaoki T. Expression and role of p27(kip1) in neuronal differentiation of embryonal carcinoma cells. Brain Res. Mol. Brain Res. 2000, 77:209-221.
61. Sell S. Leukemia: stem cells, maturation arrest, and differentiation therapy. Stem Cell Rev. 2005, 1:197-205.
62. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
63. Song Y., Lu B. Interaction of Notch signaling modulator Numb with α-Adaptin regulates endocytosis of Notch pathway components and cell fate determination of neural stem cells. J.Biol. Chem. 2012, 287:17716-17728.
64. Stone A., Sutherland R.L., Musgrove E.A. Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeutics. Crit. Rev. Oncog. 2012, 17:175-198.
65. Venugopal C., Li N., Wang X., Manoranjan B., Hawkins C., Gunnarsson T., Hollenberg R., Klurfan P., Murty N., Kwiecien J., et al. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells. Stem Cell Res. (Amst.) 2012, 8:141-153.
66. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. Cancer Genome Atlas Research Network.
67. Wang J., Wang H., Li Z., Wu Q., Lathia J.D., McLendon R.E., Hjelmeland A.B., Rich J.N. c-Myc is required for maintenance of glioma cancer stem cells. PLoS ONE 2008, 3:e3769.
68. Yan X., Ma L., Yi D., Yoon J.G., Diercks A., Foltz G., Price N.D., Hood L.E., Tian Q. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc. Natl. Acad. Sci. USA 2011, 108:1591-1596.
69. Yoon C.H., Kim M.J., Kim R.K., Lim E.J., Choi K.S., An S., Hwang S.G., Kang S.G., Suh Y., Park M.J., Lee S.J. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene 2012, 31:4655-4666.
70. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7:85.
71. Zeppernick F., Ahmadi R., Campos B., Dictus C., Helmke B.M., Becker N., Lichter P., Unterberg A., Radlwimmer B., Herold-Mende C.C. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 2008, 14:123-129.
72. Zhang L., Shen A., Ke Q., Zhao W., Yan M., Cheng C. Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells. J.Mol. Neurosci. 2012, 47:485-494.